Lowered Levels of Carbonyl Proteins after Vitamin B Supplementation in Patients with Mild Cognitive Impairment and Alzheimer's Disease

被引:20
作者
Rommer, Paulus S. [1 ]
Fuchs, Dietmar [2 ]
Leblhuber, Friedrich [3 ]
Schroth, Rainer [4 ]
Greilberger, Michaela [5 ]
Tafeit, Erwin [6 ]
Greilberger, Joachim [6 ]
机构
[1] Med Univ Vienna, Dept Neurol, Vienna, Austria
[2] Med Univ Innsbruck, Div Biochem Chem, Bioctr, A-6020 Innsbruck, Austria
[3] Landes Nervenklin, Dept Neurol & Psychiat Gerontol, Linz, Austria
[4] Sonderkrankenanstalt Schrothkur, Obervellach, Austria
[5] Schwarzl Med Ctr, Inst Laborwissensch, Graz, Austria
[6] Med Univ Graz, Inst Physiol Chem, Harrachgasse 21-2, AT-8010 Graz, Austria
关键词
Alzheimer's disease; Biomarker; Neurodegenerative disease; Vitamin B supplementation; Oxidative stress; Carbonyl proteins; IMMUNE ACTIVATION; OXIDATIVE STRESS; HOMOCYSTEINE; DEMENTIA; BLOOD; DIAGNOSIS; MARKER;
D O I
10.1159/000441565
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The critical role of neuro-inflammation and oxidative stress in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD) has become evident. Objective: The aim of this study is to assess the influence of vitamin supplementation on parameters of oxidative stress, inflammation as well as on cognition in patients with AD and mild cognitive impairment. Methods: In our study, patients with cognitive impairment and healthy controls were enrolled. All patients were intended to receive vitamin supplementation (vitamin B-1, B-6, B-12 and folic acid) for 3 months. Mini Mental State Examination (MMSE) and laboratory markers [carbonyl proteins (CPs), malondialdehyde, tryptophan (Trp), kynurenine (Kyn), neopterin, folic acid, vitamin B-12 level] were assessed for patients and controls at baseline and after 3 months. After half of the patients had been treated for 3 months, analyses were performed resulting in 3 subgroups: healthy controls without supplementation (15 subjects, 11 females), patients with vitamin supplementation (17 subjects, 10 females) and patients without vitamin supplementation (16 subjects, 9 females; baseline values prior to supplementation). Results: Age was significantly higher for the supplemented group (76.4 +/- 6.7 years) compared to vitamin-naive patients (63.3 +/- 13.7 years; p < 0.01). The MMSE score was higher in the supplemented group (23.1 +/- 4.8 vs. 20.3 +/- 9.5) but did not reach significance. Levels of CPs were significantly higher in the vitamin-na ve patients (p < 0.05). Levels of Kyn and the Kyn/Trp ratio were significantly lower in vitamin-na ve patients compared to the supplemented group (p < 0.05). No significant difference was seen for the other markers. Conclusion: Vitamin supplementation leads to reduced levels of CPs in patients. Pearson's correlation coefficient shows a negative relation (r = 0.69) between CPs and MMSE. Future trials should assess whether CPs might be suitable markers for monitoring of demented patients. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:284 / 289
页数:6
相关论文
共 31 条
[1]  
Alzheimer's Disease International (ADI), 2013, GLOB IMP DEM 2013 20
[2]   A novel role for vitamin B12: Cobalamins are intracellular antioxidants in vitro [J].
Birch, Catherine S. ;
Brasch, Nicola E. ;
McCaddon, Andrew ;
Williams, John H. H. .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (02) :184-188
[3]   Associations between Alzheimer's Disease and Blood Homocysteine, Vitamin B12, and Folate: A Case-Control Study [J].
Chen, Hui ;
Liu, Shuai ;
Ji, Lu ;
Wu, Tianfeng ;
Ma, Fei ;
Ji, Yong ;
Zhou, Yuying ;
Zheng, Miaoyan ;
Zhang, Meilin ;
Huang, Guowei .
CURRENT ALZHEIMER RESEARCH, 2015, 12 (01) :88-94
[4]   Multiple sclerosis and Alzheimer's disease [J].
Dal Bianco, Assunta ;
Bradl, Monika ;
Frischer, Josa ;
Kutzelnigg, Alexandra ;
Jellinger, Kurt ;
Lassmann, Hans .
ANNALS OF NEUROLOGY, 2008, 63 (02) :174-183
[5]   Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized Trial [J].
Dysken, Maurice W. ;
Sano, Mary ;
Asthana, Sanjay ;
Vertrees, Julia E. ;
Pallaki, Muralidhar ;
Llorente, Maria ;
Love, Susan ;
Schellenberg, Gerard D. ;
McCarten, J. Riley ;
Malphurs, Julie ;
Prieto, Susana ;
Chen, Peijun ;
Loreck, David J. ;
Trapp, George ;
Bakshi, Rajbir S. ;
Mintzer, Jacobo E. ;
Heidebrink, Judith L. ;
Vidal-Cardona, Ana ;
Arroyo, Lillian M. ;
Cruz, Angel R. ;
Zachariah, Sally ;
Kowall, Neil W. ;
Chopra, Mohit P. ;
Craft, Suzanne ;
Thielke, Stephen ;
Turvey, Carolyn L. ;
Woodman, Catherine ;
Monnell, Kimberly A. ;
Gordon, Kimberly ;
Tomaska, Julie ;
Segal, Yoav ;
Peduzzi, Peter N. ;
Guarino, Peter D. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (01) :33-44
[6]   New Developments in the Diagnosis of Dementia [J].
Eschweiler, Gerhard W. ;
Leyhe, Thomas ;
Kloeppel, Stefan ;
Huell, Michael .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (39) :677-U22
[7]   Homocysteine but not neopterin declines in demented patients on B vitamins [J].
Frick, B. ;
Gruber, B. ;
Schroecksnadel, K. ;
Leblhuber, F. ;
Fuchs, D. .
JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (11) :1815-1819
[8]   Rapid measurement of total plasma homocysteine by HPLC [J].
Frick, B ;
Schröcksnadel, K ;
Neurauter, G ;
Wirleitner, B ;
Artner-Dworzak, E ;
Fuchs, D .
CLINICA CHIMICA ACTA, 2003, 331 (1-2) :19-23
[9]   Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease [J].
Greilberger, J. ;
Koidl, C. ;
Greilberger, M. ;
Lamprecht, M. ;
Schroecksnadel, K. ;
Leblhuber, F. ;
Fuchs, D. ;
Oettl, K. .
FREE RADICAL RESEARCH, 2008, 42 (07) :633-638
[10]  
Greilberger J, 2010, CLIN LAB, V56, P441